Cervical Plexus Blocks for Postoperative Pain
Trial Summary
What is the purpose of this trial?
This is a single center, prospective, double-blinded randomized controlled trial comparing the efficacy of bilateral superficial cervical plexus blocks (BSCPB) with local wound infiltration vs placebo with local wound infiltration in reducing thyroid surgery postoperative pain. Primary outcomes assessed are post operative pain, quality of life/recovery, post operative nausea/vomiting and opioid use.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have used opioids or pain medications in the two weeks before surgery.
What data supports the effectiveness of the treatment Bilateral Superficial Cervical Plexus Blocks and Local Wound Infiltration for postoperative pain?
Research shows that bilateral superficial cervical plexus blocks, when used with general anesthesia, can help manage pain after thyroid surgery, although some studies found no significant reduction in pain medication needs. This suggests that while the treatment may not always reduce the need for additional pain relief, it could still offer some benefits in managing postoperative pain.12345
Is the cervical plexus block safe for humans?
How does the treatment of Bilateral Superficial Cervical Plexus Blocks and Local Wound Infiltration differ from other treatments for postoperative pain?
This treatment is unique because it combines a bilateral superficial cervical plexus block, which targets specific nerves in the neck to provide localized pain relief, with local wound infiltration, offering a dual approach to managing postoperative pain. Unlike some other treatments, it focuses on site-specific pain relief with minimal side effects, enhancing recovery quality.12347
Eligibility Criteria
This trial is for adults over 18 who can consent and are having thyroid surgery (hemi- or total thyroidectomy). It's not for those with previous neck surgeries, coagulation disorders, kidney issues, pregnancy, bupivacaine allergy, chronic pain conditions, recent steroid or opioid use, substernal goiters, or an inability to take NSAIDs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Enrollment
Enrollment period until 74 participants are acquired
Treatment
Participants undergo thyroid surgery with either bilateral superficial cervical plexus blocks or placebo
Immediate Postoperative Monitoring
Participants are observed for at least 4 hours in the post anesthesia care unit for postoperative complications and pain control
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain and quality of recovery assessments
Treatment Details
Interventions
- Bilateral Superficial Cervical Plexus Blocks and Local Wound Infiltration
- Placebo Injection and Local Wound Infiltration
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor